Peer-Reviewed Journal Details
Mandatory Fields
Mahalingam, D,Natoni, A,Keane, M,Samali, A,Szegezdi, E
2010
February
British Journal Of Cancer
Early growth response-1 is a regulator of DR5-induced apoptosis in colon cancer cells
Published
()
Optional Fields
tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) early growth response gene-1 (Egr-1) death receptor 5 (DR5) type I extrinsic apoptotic pathway cellular FLICE inhibitory protein (c-FLIP) colon carcinoma FINGER TRANSCRIPTION FACTORS TRAIL-INDUCED APOPTOSIS DEATH RECEPTORS DIFFERENTIAL MODULATION SIGNALING PATHWAYS COLORECTAL-CANCER PROSTATE-CANCER DOWN-REGULATION EGR-1 EXPRESSION
102
754
764
BACKGROUND: Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) induces tumour cell apoptosis by binding to death receptor 4 (DR4) and DR5. DR4 and DR5 activation however can also induce inflammatory and pro-survival signalling. It is not known how these different cellular responses are regulated and what the individual role of DR4 vs DR5 is in these processes.METHODS: DNA microarray study was carried out to identify genes differentially expressed after DR4 and DR5 activation. RT-PCR and western blotting was used to examine the expression of early growth response gene-1 (Egr-1) and the proteins of the TRAIL signalling pathway. The function of Egr-1 was studied by siRNA-mediated knockdown and overexpression of a dominant-negative version of Egr-1.RESULTS: We show that the immediate early gene, Egr-1, regulates TRAIL sensitivity. Egr-1 is constitutively expressed in colon cancer cells and further induced upon activation of DR4 or DR5. Our results also show that DR4 mediates a type II, mitochondrion-dependent apoptotic pathway, whereas DR5 induces a mitochondrion-independent, type I apoptosis in HCT15 colon carcinoma cells. Egr-1 drives c-FLIP expression and the short splice variant of c-FLIP (c-FLIPS) specifically inhibits DR5 activation.CONCLUSION: Selective knockdown of c-FLIPS sensitises cells to DR5-induced but not DR4-induced apoptosis and Egr-1 exerts an effect as an inhibitor of the DR5-induced apoptotic pathway, possibly by regulating the expression of c-FLIPS. British Journal of Cancer (2010) 102, 754-764. doi:10.1038/sj.bjc.6605545 www.bjcancer.com Published online 19 January 2010 (C) 2010 Cancer Research UK
DOI 10.1038/sj.bjc.6605545
Grant Details
Publication Themes